Leucadia National Corporation »

Fate Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $160k 59k 2.70

More positions owned by Leucadia National Corporation

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust St Str Sp Biot (XBI)
Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
Advanced Micro Devices (AMD)
Meta Platforms Cl A (META)
Amazon (AMZN)
Iren Ordinary Shares (IREN)
NVIDIA Corporation (NVDA)
Ark Etf Tr Genomic Rev Etf (ARKG)
Automatic Data Processing (ADP)
Cloudflare Cl A Com (NET)

View all positions for Leucadia National Corporation

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
AQR Capital Management
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies
Millennium Management
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Jane Street
Citadel Advisors

View all funds holding Fate Therapeutics